Showing results (151-160 of 195) with videos related to

Sort By:
Pageof 20
The Journal of Investigative Dermatology|January 5, 2000
Genotype/phenotype and penetrance studies in melanoma families with germline CDKN2A mutationsJ A Bishop, R C Wachsmuth, M Harland, et al.
Cancer Treatment Reports|January 1, 1987
Overview of randomized trials of postoperative adjuvant radiotherapy in breast cancerJ Cuzick, H Stewart, R Peto, et al.
Lancet (London, England)|June 13, 1992
Mild cervical dyskaryosis: safety of cytological surveillanceM H Jones, D Jenkins, J Cuzick, et al.
The Lancet. Oncology|August 5, 2006
Comprehensive side-effect profile of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: long-term safety analysis of the ATAC trial, A Buzdar, A Howell, et al.
British Journal of Cancer|August 17, 2000
A systematic review of the role of human papilloma virus (HPV) testing within a cervical screening programme: summary and conclusionsJ Cuzick, P Sasieni, P Davies, et al.
International Journal of Cancer|December 1, 1981
A prospective study of plasma prolactin levels and subsequent risk of breast cancerH G Kwa, F Cleton, D Y Wang, et al.
Human Molecular Genetics|December 1, 1994
Genetic heterogeneity in familial malignant melanomaC MacGeoch, J A Bishop, V Bataille, et al.
Ecancermedicalscience|March 17, 2012
Aspirin for the older person: report of a meeting at the Royal Society of Medicine, London, 3rd November 2011J Armitage, J Cuzick, P Elwood, et al.
BJOG : an International Journal of Obstetrics and Gynaecology|December 11, 2003
The ATAC adjuvant breast cancer trial in postmenopausal women: baseline endometrial subprotocol dataS Duffy, T L Jackson, M Lansdown, et al.
British Journal of Cancer|June 4, 2014
Improving decision making about clinical trial participation - a randomised controlled trial of a decision aid for women considering participation in the IBIS-II breast cancer prevention trialI Juraskova, P Butow, C Bonner, et al.
Pageof 20